Zevra Therapeutics Inc (ZVRA)

Stock-Based Compensation

$2.97M

Quarterly · Period ending: · USD

ZVRA logo

ZVRA Stock-Based Compensation

Latest reported$2.97M
ZVRA Quarterly Stock-Based Comp ($24.64K → $2.97M)
High-resolution chart · PNG

ZVRA stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
2,969,000
3,105,000
4,284,000
2,771,000
2,464,000
3,115,000
4,018,000
6,137,000
2,632,000
2,119,000
2,962,000
1,387,000
2,151,000
945,000
0
911,000
1,510,000
918,000
823,000
620,000
318,000
675,000
457,000
385,000
620,000
1,029,000
746,000
1,057,000
1,317,000
1,290,000
1,250,000
2,586,000
1,378,000
1,281,000
1,150,000
1,158,000
1,165,000
1,089,000
1,042,000
3,279,000
1,257,000
1,022,000
913,000
492,000
873,000
91,000
44,758
52,000
91,000
26,000
24,644
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.